Work

OAB-052: Impact of chromosome 1 abnormalities on newly diagnosed multiple myeloma treated with proteasome inhibitor, immunomodulatory drug, and dexamethasone: analysis from the ENDURANCE ECOG-ACRIN E1A11 trial

Year: 2021

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(21)02126-1

Authors: Prashant Kapoor, Timothy Schmidt, Susanna Jacobus, Zihan Wei, Rafael Fonseca, Natalie S. Callander, Sagar Lonial, S. Vincent Rajkumar, Shaji Kumar

Institutions: Mayo Clinic, University of Wisconsin–Madison, Dana-Farber Cancer Institute, University of Wisconsin Carbone Cancer Center, Emory University, Winship Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211890369

Cites:

Cited by: 16

Related to: 10